Senior CRA-led monitoring support designed to improve protocol compliance, data quality , and site performance across all phases of clinical trials.
Focused, risk-based monitoring services that ensure compliance, data integrity, and operational excellence at every step.
Ensuring compliance with global regulations and inspection readiness.
Data quality oversight and process quality throughout the study.
Focused on critical data and processes aligned with ICH E6(R3).
Monitoring is the single most critical function in clinical trial execution—and one of the most common points of failure.
Clinara provides experienced, senior-level CRA support to ensure:
We focus on critical data and processes—not just routine visits—aligned with ICH E6(R3) principles.
We build working relationships with sites to improve responsiveness, compliance, and execution.
We identify site risks, protocol drift, and data quality issues early—before they impact timelines or audits.
Monitoring reports, escalations, and sponsor updates are delivered quickly and clearly.
End-to-end CRA support across all phases.
Stabilizing underperforming sites and trials.
Rapid deployment of experienced CRAs.
Flexible, scalable monitoring aligned with sponsor needs.
Ensure site readiness for trial initiation.
Ensure trial compliance and data quality.
Ensure proper trial closure and document completion
Ensure study oversight via remote/hybrid monitoring.
challenge : high query backlog and inconsistent monitoring across sites.
clinara solution : deployed senior CRA support with targeted oversight.
outcome : reduced open queries by 42% within 6 weeks and improved protocol adhrence.
reduction in
open queries
results achieved
within
challenge : site performance delays and rising protocol deviations.
clinara solution : reduce monitoring and rapid escalation strategy.
outcome : stabilized enrollment and reduced deviation frequency within 2 monitoring cycles.
stabilized site performance
fewer deviations within 2 cycles
Every study is managed by experienced professionals.
quick response to issues. smarter outcomes.
low turnover. strong relationships. better continuity.
driving enrollment, data quality, and investigator engagement.
less bureaucracy. more action. results that matter.
CNS, Oncology, Metabolic, Cardiovascular, Vaccines, Rare Disease & more
we can assess your study and propose
coverage within 48 hours.
Helping businesses maximize their online potential through data-driven conversion optimization.
